Insights from IIgANN 2025 in Prague: Advancing the Science and Shaping the Future of IgA Nephropathy
Chris Christodoulou, Senior Manager, Scientific and Medical Affairs The IIgANN 2025 Symposium,…
by Tony Proctor1 In the current climate of capital constraints, tariffs and…
Tamara Murdock, Global Head, Early Phase Describe the collaborative nature of an…
Renal drug development is going through a renaissance of sorts as the…
Clinical development today is operating under a very different set of conditions…
By Tony Proctor and Abdul Rastagar The clinical trial industry is navigating…
In a world where more efficient and better targeted treatments are being…